• Degarelix Acetate: Mechanistic Insights and Translational Im

  2026-07-20

  Explore how Degarelix acetate, a potent GnRH receptor antagonist, is reshaping prostate cancer research through advanced mechanistic understanding and translational assay design. This article offers unique analysis, protocol guidance, and actionable insights beyond standard reviews.

• Self-Adaptive Nanocarriers for Overcoming Pancreatic Tumor B

  2026-07-20

  This study presents a dual pH/ROS-sensitive nanocarrier (DATCPT) designed to surmount the dense extracellular matrix and physiological barriers of orthotopic pancreatic cancer, thereby enhancing chemotherapeutic delivery and efficacy. The work demonstrates the utility of ROS-mediated mechanisms for targeted drug release and matrix remodeling, with broad implications for nanomedicine strategies in treatment-resistant tumors.

• WY-14643 (Pirinixic Acid) in Metabolic and Liver Regeneratio

  2026-07-19

  WY-14643 (Pirinixic Acid) stands out as a selective PPARα agonist enabling advanced metabolic disorder and liver regeneration research. Leveraging recent mechanistic insights and robust workflows, researchers can optimize protocols for reproducibility and translational impact.

• Polyploid Giant Cancer Macrophages as Biomarkers of Tumor Pr

  2026-07-18

  This study provides a comprehensive phenotypic and clinical evaluation of circulating polyploid giant cancer macrophages (CAMLs) across multiple solid tumors. The findings establish CAMLs as a robust indicator of disease progression and metastatic niche formation, offering new directions for translational cancer research.

• MARCH5 Regulates Mitochondria-Derived Pre-Peroxisome Formati

  2026-07-17

  Zheng et al. reveal that the ubiquitin ligase MARCH5 is essential for the formation of PEX3-containing vesicles from mitochondria, a newly clarified step in peroxisome biogenesis. This work identifies key domains of MARCH5 critical for pre-peroxisome genesis and highlights its selectivity, advancing understanding of mitochondrial-peroxisomal interplay.

• Necrostatin-1: Precision RIP1 Kinase Inhibition in Necroptos

  2026-07-17

  Necrostatin-1 (Nec-1) enables researchers to dissect necroptosis with high specificity, providing a robust platform for RIP1 kinase pathway interrogation, disease modeling, and inflammation studies. This article details applied workflows, practical troubleshooting, and insights drawn from cutting-edge research to optimize results with Nec-1.

• Anti-ROR1 Antibody (Zilovertamab): Optimizing Cancer Assays

  2026-07-16

  Anti-ROR1 Antibody (Zilovertamab) enables precise inhibition of Wnt5a-induced ROR1 signaling, empowering advanced cancer and liver injury research. Explore robust experimental workflows, protocol enhancements, and troubleshooting insights to maximize reproducibility and specificity in ELISA, FACS, and animal models.

• Optimizing B-Cell Assays with Ibrutinib (PCI-32765) BTK Inhi

  2026-07-16

  This in-depth guide addresses common laboratory challenges in B-cell viability and proliferation assays, demonstrating how 'Ibrutinib (PCI-32765) Bruton's Tyrosine Kinase (BTK) Inhibitor' (SKU A3001) from APExBIO offers quantifiable improvements in reproducibility and data clarity. Practical Q&A scenarios highlight protocol optimization, data interpretation, and vendor reliability for researchers seeking robust, evidence-based experimental outcomes.

• Fangchinoline Restores TFEB-Driven Lysosomal Biogenesis in H

  2026-07-15

  This study demonstrates that fangchinoline, a bisbenzylisoquinoline alkaloid, restores TFEB-mediated lysosomal biogenesis disrupted by H1N1 influenza infection. The work highlights a host-directed antiviral strategy by modulating lysosomal function, with implications for developing new therapeutic approaches targeting viral immune evasion.

• Natural Product Inhibitors Target NSP15 of SARS-CoV-2

  2026-07-15

  The referenced study identifies thymopentin and oleuropein as potent inhibitors of the SARS-CoV-2 NSP15 endoribonuclease, using structure-based virtual screening and molecular dynamics. These findings highlight the importance of NSP15 as an antiviral target and suggest new directions for COVID-19 therapeutic development.

• ECL Western Blotting Substrate: Technical Parameters & Workf

  2026-07-14

  ECL Western Blotting Substrate (SKU K2187) enables sensitive, nonradioactive detection of HRP in Western blot assays, supporting clear chemiluminescent signal capture and reliable protein analysis in molecular and cancer biology. It is not suitable for applications requiring fluorescent or radioisotopic labeling and should be used according to luminol-based chemiluminescent detection protocols.

• RepSox (ALK5 Inhibitor): Redefining iPSC Differentiation Eff

  2026-07-14

  Explore how RepSox, a potent ALK5 inhibitor, unlocks new efficiencies in induced pluripotent stem cell reprogramming and differentiation. This article delivers a deeper mechanistic dive and practical guidance for advanced TGF-β pathway modulation in cell biology research.

• ISR Inhibition Prevents Memory Loss and Accelerated Forgetti

  2026-07-13

  This study demonstrates that activation of the integrated stress response (ISR) underlies both natural and epilepsy-associated accelerated forgetting in mice. Pharmacological inhibition of the ISR with ISRIB (trans-isomer) preserved established memories and counteracted seizure-induced memory loss, revealing a mechanistic link between cellular stress signaling and memory persistence.

• n-Dodecyl-β-D-maltoside: Unlocking Membrane Protein Science

  2026-07-13

  This article explores how n-Dodecyl-β-D-maltoside (DDM), a non-ionic detergent, revolutionizes membrane protein research by enabling robust purification, stabilization, and functional analysis, with a focus on translational applications such as targeting Mycobacterium tuberculosis WecA. Drawing from recent breakthroughs and real-world protocols, we outline strategic guidance for researchers aiming to overcome the enduring challenges of membrane protein biochemistry.

• GS-441524 Prodrug Pathways: Applied Workflows & Optimization

  2026-07-12

  GS-441524, a potent nucleoside analog, is redefining antiviral assay development by offering insight into prodrug conversion and pharmacokinetics. This guide translates recent LC–MS/MS discoveries into actionable experimental strategies, highlighting workflow enhancements, troubleshooting, and the critical role of APExBIO's research-grade GS-441524 in translational science.

454 records 11/31 page Previous Next First page 上5页 1112131415 下5页 Last page